This podcast was recorded on July 21, 2025. Tim Beyers: Is it time to buy biotech? You're listening to Motley Fool Money.

Cryotherapy, infant stem cells, extreme cold, IV infusions, red light therapy, blue light therapy … more Australians are ...

A new study in mice has found that muscle loss associated with weight loss from GLP-1 medications like Ozempic may not be as ...

Cheryl Burke is setting the record straight about her weight loss after months of facing Ozempic and cosmetic surgery rumors.

CINCINNATI — U.S. Customs and Border Protection (CBP) and the U.S. Food and Drug Administration (FDA) at the port of ...

Ozempic isn’t just for weight loss—studies show it could help prevent strokes. Discover what this means for you, and what ...

Nearly 12% of Americans have used GLP-1 drugs for weight loss, including about one-fifth of women aged 50 to 64, according to ...

As the list of health benefits of semaglutide drugs grows, perhaps it is time to think about assessing their impact on people ...

European giant Novo Nordisk vowed to lower prices for its popular weight-loss drug to reach more U.S. customers.

Clifford Segil, DO, a neurologist at Providence Saint John’s Health Center in Santa Monica, CA, agrees. “Lowering a person’s ...

Burke previously spoke about the body shaming she endured after gaining weight during her 26 seasons on Dancing with the Stars — including being told she was “too fat” for TV at age 21. Earlier this ...

Novo Nordisk (NVO) offered investors an update about ongoing cost-cutting efforts as copycat weight-loss drugs weigh on sales ...